Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice
- PMID: 16303950
- DOI: 10.1167/iovs.05-0723
Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice
Abstract
Purpose: To determine the effect of bimatoprost on intraocular pressure in the prostaglandin FP receptor knockout mouse.
Methods: The IOP response to a single 1.2-microg (4 microL) dose of bimatoprost was measured in the treated and untreated fellow eyes of homozygote (FP+/+, n = 9) and heterozygote (FP+/-, n = 10) FP-knockout mice, as well as in wild-type C57BL/6 mice (FP+/+, n = 20). Serial IOP measurements were also performed after topical bimatoprost in a separate generation of homozygous FP-knockout mice and wild-type littermate control animals (n = 4 per group). Aqueous humor protein concentrations were measured to establish the state of the blood-aqueous barrier. Tissue, aqueous humor and vitreous concentrations of bimatoprost, latanoprost, and their C-1 free acids were determined by liquid chromatography and tandem mass spectrometry.
Results: A significant reduction in IOP was observed in the bimatoprost-treated eye of wild-type mice at 2 hours, with a mean difference and 95% confidence interval (CI) of the difference in means of -1.33 mm Hg (-0.81 to -1.84). Bimatoprost did not lead to a significant reduction in IOP in either the heterozygous knockout -0.36 mm Hg (-0.82 to +0.09) or homozygous FP-knockout mice 0.25 mm Hg (-0.38 to +0.89). The lack of an IOP response in the FP-knockout mice was not a consequence of blood-aqueous barrier breakdown, as there was no significant difference in aqueous humor protein concentration between treated and fellow eyes. Tissue and aqueous humor concentrations of bimatoprost, latanoprost, and their C-1 free acids indicate that latanoprost, but not bimatoprost, is hydrolyzed in the mouse eye after topical administration.
Conclusions: An intact FP receptor gene is critical to the IOP response to bimatoprost in the mouse eye.
Similar articles
-
Effect of latanoprost on intraocular pressure in mice lacking the prostaglandin FP receptor.Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3555-9. doi: 10.1167/iovs.04-0338. Invest Ophthalmol Vis Sci. 2004. PMID: 15452062
-
The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4159-63. doi: 10.1167/iovs.05-0494. Invest Ophthalmol Vis Sci. 2005. PMID: 16249494
-
Prostaglandin FP receptors do not contribute to 24-hour intraocular pressure variation in mice.Invest Ophthalmol Vis Sci. 2007 May;48(5):2095-8. doi: 10.1167/iovs.06-0516. Invest Ophthalmol Vis Sci. 2007. PMID: 17460266
-
A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.Curr Med Res Opin. 2007 Mar;23(3):601-8. doi: 10.1185/030079907X178720. Curr Med Res Opin. 2007. PMID: 17355741 Review.
-
Update on the mechanism of action of bimatoprost: a review and discussion of new evidence.Surv Ophthalmol. 2004 Mar;49 Suppl 1:S5-11. doi: 10.1016/j.survophthal.2003.12.014. Surv Ophthalmol. 2004. PMID: 15016556 Review.
Cited by
-
The biodisposition and hypertrichotic effects of bimatoprost in mouse skin.Exp Dermatol. 2013 Feb;22(2):145-8. doi: 10.1111/exd.12071. Epub 2013 Jan 2. Exp Dermatol. 2013. PMID: 23278986 Free PMC article.
-
Travoprost in the management of open-angle glaucoma and ocular hypertension.Clin Ophthalmol. 2007 Mar;1(1):11-24. Clin Ophthalmol. 2007. PMID: 19668462 Free PMC article.
-
Prostamides (prostaglandin-ethanolamides) and their pharmacology.Br J Pharmacol. 2008 Feb;153(3):410-9. doi: 10.1038/sj.bjp.0707434. Epub 2007 Aug 27. Br J Pharmacol. 2008. PMID: 17721551 Free PMC article. Review.
-
Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.Br J Pharmacol. 2019 Apr;176(8):1059-1078. doi: 10.1111/bph.14335. Epub 2018 Jun 7. Br J Pharmacol. 2019. PMID: 29679483 Free PMC article. Review.
-
Remodeling of the Lamina Cribrosa: Mechanisms and Potential Therapeutic Approaches for Glaucoma.Int J Mol Sci. 2022 Jul 22;23(15):8068. doi: 10.3390/ijms23158068. Int J Mol Sci. 2022. PMID: 35897642 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases